In this study, our observations provided evidence that Rh2 can effectively ameliorate AD-like skin symptoms via the inhibition of the expression of TSLP in keratinocytes following the suppression of the NF-κB signaling pathway, along with the modulation of Th2 cell differentiation and effector functions. This evidence concerns the gene NFKB1 and Alzheimer disease.